Interpace Biosciences Announces Impending Delisting from Nasdaq
17 févr. 2021 08h00 HE
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, today announced that on...